Volume Spike Investor

As you will see below, Novavax, Inc. (NASDAQ: NVAX), Generex Biotechnology Corp. (NASDAQ: GNBT), BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX), Pure Bioscience (NASDAQ: PURE), Vical Inc (NASDAQ: VICL), Meridian Bioscience Inc. (NASDAQ: VIVO), and AVI BioPharma Inc. (NASDAQ: AVII) have all begun their overbought roll-over.  Full analysis can be found at 24/7 Wall Street.

Novavax, Inc. (NVAX) is down 13% at $2.75; shares were at $0.81 last Thursday and closed at $1.42 last Friday (and hit $3.88 Monday).

Generex Biotechnology Corp. (GNBT) is down 22% at $0.44; shares were at $0.27 last Thursday and closed at $0.34 last Friday (and hit $0.70 yesterday).

BioCryst Pharmaceuticals Inc. (BCRX) is down 18% at $3.41; shares were at $1.75 last Thursday and closed at $2.21 last Friday (hit $4.89 Monday).

Pure Bioscience (PURE) is down 10% at $10.58; shares were at $1.75 last Thursday and closed at $1.85 last Friday (hit $3.19 Monday).

Vical Inc (VICL) is down almost 7% at $2.27; shares were at $2.40 last Thursday and closed at $2.53 last Friday (hit $3.30 Monday).

Meridian Bioscience Inc (VIVO) are flat today at $17.80; shares were at $16.13 last Thursday and closed at $16.24 last Friday (and hit $18 on Monday).

AVI BioPharma Inc. (AVII) is down 10% at $0.878; shares were at $0.74 last Thursday and closed at $0.89 last Friday (and hit $1.29 Monday).

JON C. OGG